|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1348602383 |
003 |
OCoLC |
005 |
20231120010709.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
221024s2023 ne o 001 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d OCLCF
|d OCLCO
|
020 |
|
|
|z 9780443186165
|q (print)
|
035 |
|
|
|a (OCoLC)1348602383
|
050 |
|
4 |
|a RM301.25
|
082 |
0 |
4 |
|a 615.1/9
|2 23
|
245 |
0 |
0 |
|a Fused pyrimidine-based drug discovery /
|c edited by Raj Kumar.
|
264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier,
|c [2023]
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Heterocyclic drug discovery
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed October 24, 2022).
|
650 |
|
0 |
|a Drug development.
|
650 |
|
0 |
|a Pyrimidines.
|
650 |
|
2 |
|a Pyrimidines
|0 (DNLM)D011743
|
650 |
|
6 |
|a M�edicaments
|x D�eveloppement.
|0 (CaQQLa)201-0306620
|
650 |
|
6 |
|a Pyrimidines.
|0 (CaQQLa)201-0018110
|
650 |
|
7 |
|a Drug development
|2 fast
|0 (OCoLC)fst00898670
|
650 |
|
7 |
|a Pyrimidines
|2 fast
|0 (OCoLC)fst01084653
|
700 |
1 |
|
|a Kumar, Raj
|c (Associate professor),
|e editor.
|
830 |
|
0 |
|a Heterocyclic drug discovery.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780443186165
|z Texto completo
|